step 01
Evaluate
Jupiter evaluates dozens of potential "moons" using a set of investment criteria, with a primary focus on unmet medical need.
step 02
De-risk
Jupiter deploys small amounts of seed capital (less than $1.5M per moon) to validate key results and secure intellectual property. Jupiter team members work with moon founders to de-risk moons. Jupiter’s “fail fast” innovation model anticipates that some moons fail at this stage.
step 03
Grow
At this stage, Jupiter invests up to $5M per moon and also recruits non-Jupiter venture investors to join the syndicate. Drug candidates are nominated. Jupiter team members continue to serve as interim leadership.
Moon
Moon
Moon
Moon
Moon
Moon
step 04
Protect
Moons are now freestanding, high-value biotech companies with sufficient capital to demonstrate proof-of-concept in humans. Moons are now led by a permanent non-Jupiter leadership team. Jupiter deploys up to $20M over the life of a moon.
